MAMDC4
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| MAM domain containing 4 | MIM:617208 | Ensembl:ENSG00000177943 | HGNC:HGNC:24083 | PA142671487 | 9q34.3 |
GO terms in MAMDC4
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| BP | IEA | GO:0015031 | protein transport |
| CC | IEA | GO:0016021 | integral component of membrane |
Gene expression in normal tissue: MAMDC4
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in MAMDC4
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD314 | Tanespimycin | 2 |
| iGMDRD132 | (-)-gallocatechin-3-O-gallate | 3 |
| iGMDRD523 | Cyanoquinoline, 11 | 3 |
| iGMDRD405 | PIK-75 | 1 |
| iGMDRD79 | Gemcitabine | 5 |
| iGMDRD424 | Tamatinib | 2 |
| iGMDRD269 | Purmorphamine | 2 |
| iGMDRD286 | Nsc 632839 | 2 |
| iGMDRD872 | BRD7137 | 3 |
| iGMDRD300 | Tozasertib | 4 |
| iGMDRD77 | Itraconazole | 2 |
| iGMDRD221 | Tamoxifen | 2 |
| iGMDRD61 | Kinetin riboside | 7 |
| iGMDRD446 | LY 2183240 | 5 |
| iGMDRD201 | SKI II | 1 |
| iGMDRD375 | GW-405833 | 5 |
| iGMDRD679 | Bistramide A | 1 |
| iGMDRD280 | CYTOCHALASIN B | 2 |
| iGMDRD889 | Compound 7d-cis | 3 |
| iGMDRD579 | PF750 | 2 |
| iGMDRD781 | Sirolimus | 3 |
| iGMDRD144 | NSC95397 | 5 |
| iGMDRD546 | BMS-754807 | 1 |
| iGMDRD427 | ABT737 | 4 |
| iGMDRD577 | BIX01294 | 2 |
| iGMDRD506 | Fedratinib | 5 |
| iGMDRD562 | Navitoclax | 4 |
| iGMDRD188 | Piperlongumine | 3 |
| iGMDRD399 | Selumetinib | 2 |
| iGMDRD23 | Gossypol | 3 |
| iGMDRD802 | 4-methylfasudil | 3 |
| iGMDRD255 | SB225002 | 4 |
| iGMDRD474 | Avrainvillamide | 2 |
| iGMDRD885 | Compound 110 | 2 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in MAMDC4
CLASSFICATION
Copyright © 2018 Modellab | All Rights Reserved
Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.